Antithrombotic agents are an integral component of the medical regimens and interventional
strategies currently recommended to reduce thrombotic complications in patients with acute …

Plaque erosions and ruptures are the histopathological hallmarks of arterial thrombus
formation in the coronary arteries. The clinical condition associated with this process is …

Antiplatelet and antithrombotic agents significantly alter the clinical course of patients with
acute coronary syndrome (ACS) and hence form the bedrock of the management pathway of …

A few decades ago, the understanding of the pathophysiological processes involved in the
coronary artery thrombus formation has placed anticoagulant and antiplatelet agents at the …

In patients undergoing percutaneous coronary intervention (PCI) for acute coronary
syndrome (ACS), both periprocedural acute myocardial infarction and bleeding …

The platelet plays an essential role in atherothrombosis. Clinically, platelet-rich thrombi
underlie acute coronary syndromes (ACSs). Current therapies have improved outcomes …

Antithrombotic therapy represents the cornerstone of the pharmacological treatment in
patients with acute coronary syndrome (ACS). The optimal combination and duration of …

Antithrombotic Therapy after Acute Coronary Syndromes Antithrombotic therapy is a central
component of treatment after acute coronary syndromes. The focus is on antiplatelet therapy …

Antithrombotic therapy is a cornerstone of treatment for non-ST-segment elevation acute
coronary syndromes, as demonstrated in numerous clinical trials. Long-term oral antiplatelet …

Mortality and morbidity in acute coronary syndromes (ACSs), caused principally by plaque
erosion or rupture leading to thrombus formation and myocardial ischemia, have been …